Fenofibrate effective in treatment of COVID-19 | Prof. Yaakov Nahmias | Hebrew University

Prof. Yaakov Nahmias | August 17, 2021

Hebrew University interventional open-label study led by Prof. Yaakov Nahmias on 15 severe COVID-19 patients requiring oxygen support shows that 145 mg/day fenofibrate (TriCor) reduced inflammation in 48 hours and eliminated the need for oxygen support within 5 to 7 days of hospitalization.

Be the First to Know

Sign up to get updates when we add new off-label treatments, articles, videos, and clinical trials!